Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

Share Price is delayed by 15 minutes
Get Live Data
2,320.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 5.00 (0.216%)
Market Cap: £3.15b
RCP Live PriceLast checked at - London Stock Exchange

Intraday RIT Capital Partners Share Chart

Net Asset Value(s)

15 Jun 2023 07:00

RNS Number : 7618C
RIT Capital Partners PLC
15 June 2023
 

RIT CAPITAL PARTNERS PLC (LEI: P31Q1NLTW35JJGHA4667)

15 June 2023

31 May 2023 Net Asset Value

The unaudited diluted net asset value (NAV) of RIT Capital Partners plc as at 31 May 2023 (with debt at fair value) was 2,348p per £1 ordinary share (30 April 2023: 2,367p).

 

May 2023 Highlights

Global equity markets were flat in May, although this concealed wide differences in performance across and within regional indices. For example, the FTSE All-share declined by -4.7%, China's CSI 300 was down -5.6%, and the S&P 500 equal-weighted index was down -3.8%. By contrast, the focus on Artificial Intelligence boosted a select group of mega-cap technology shares, pushing the NASDAQ 100 higher by nearly +7.7%. Economic news was also mixed with survey data indicating further weakness in the manufacturing sector, whilst services proved more robust. 

· The Quoted Equities book saw positive performance from Japan and Value holdings, offset by weakness in China and Quality Defensive holdings.

· In our Private Investments book, as of 31 May, ~76% of our private funds had reported valuations to 31 March, with ~24% held at 31 December valuations. Q1 marks received to date have led to a positive contribution to NAV, mainly driven by gains from holdings in the Digital Transition theme.

· Our Uncorrelated Strategies book was flat as positive contributions from European credit strategies were offset by market neutral strategies and a decline in the gold price.

· Currency movements contributed positively during the month, reflecting our active risk management approach to currency exposure in the portfolio.

· The Board continued to buy back shares during the month, directly benefitting shareholders via the accretive impact to NAV per share. In the month of May, the company repurchased approximately 1.0 million shares on behalf of shareholders.

· We continue to hold a substantial liquidity balance in the portfolio. As at 31 May, total cash and short-term gilts were approximately £369 million.

 

About RIT Capital Partners plc

RIT Capital Partners plc is an investment company listed on the London Stock Exchange. The Company's investment manager is J. Rothschild Capital Management Limited (JRCM), led by its Executive Committee: CEO Francesco Goedhuis, CIO Ron Tabbouche, CFOO Andrew Jones and CSO Aron Balas. JRCM is authorised and regulated by the FCA.

Website: www.ritcap.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVDZLFFXQLFBBB
Date   Source Headline
12th Apr 20197:00 amRNSNet Asset Value(s)
3rd Apr 20193:59 pmRNSQUARTERLY DISCLOSURE - Listing Rule 15.6.8
22nd Mar 20194:01 pmRNSDirector/PDMR Shareholding
14th Mar 20197:00 amRNSNet Asset Value(s)
5th Mar 20197:00 amRNSAnnual Financial Report
18th Feb 20197:00 amRNSNet Asset Value(s)
5th Feb 20197:00 amRNSNet Asset Value(s)
8th Jan 201910:02 amRNSQuarterly Disclosure: Listing Rule 15.6.8
14th Dec 20187:00 amRNSNet Asset Value(s)
30th Nov 201810:53 amRNSComposition of Board Committee
14th Nov 20187:00 amRNSNet Asset Value(s)
29th Oct 20184:59 pmRNSComposition of Board Committee
16th Oct 201811:11 amRNSDirector Declaration
12th Oct 20187:00 amRNSNet Asset Value(s)
5th Oct 20185:03 pmRNSDirector/PDMR Shareholding
4th Oct 20185:46 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
14th Sep 20187:00 amRNSNet Asset Value(s)
24th Aug 20183:15 pmRNSAppointment of Joint Broker
14th Aug 20187:00 amRNSNet Asset Value(s)
7th Aug 20187:00 amRNSHalf-year Report
18th Jul 20187:00 amRNSNet Asset Value(s)
3rd Jul 20186:00 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
14th Jun 20187:00 amRNSNet Asset Value(s)
15th May 20187:00 amRNSNet Asset Value(s)
26th Apr 201812:41 pmRNSDirectorate Change
26th Apr 201812:27 pmRNSResult of AGM
16th Apr 20187:25 amRNSNet Asset Value(s)
6th Apr 20185:54 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
28th Mar 20185:09 pmRNSDirector/PDMR Shareholding
26th Mar 201811:54 amRNSDirectorate Change
14th Mar 20187:00 amRNSNet Asset Value(s)
5th Mar 20186:00 pmRNSDirector/PDMR Shareholding
27th Feb 20187:00 amRNSFinal Results and Dividend
14th Feb 20187:00 amRNSNet Asset Value(s)
5th Feb 201810:02 amRNSInitiation research from QuotedData
31st Jan 20187:00 amRNSNet Asset Value(s)
22nd Dec 201710:08 amRNSDirector/PDMR Shareholding
22nd Dec 20177:00 amRNSDirectorate Change
20th Dec 20174:17 pmRNSDirector Declaration
14th Dec 20177:00 amRNSNet Asset Value(s)
27th Nov 20175:54 pmRNSDirector/PDMR Shareholding
16th Nov 20175:28 pmRNSComposition of Board Committee
14th Nov 20177:00 amRNSNet Asset Value(s)
19th Oct 20174:19 pmRNSDirectorate Change
16th Oct 20177:00 amRNSNet Asset Value(s)
14th Sep 20177:00 amRNSNet Asset Value(s)
14th Aug 20177:00 amRNSNet Asset Value(s)
14th Aug 20177:00 amRNSHalf-year Report
21st Jul 201710:00 amRNSDirectorate Change
18th Jul 20177:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.